ARCUS BIOSCIENCES INC (RCUS:NYSE)
$27.84 -0.58 (-2.0408%)
Analysed ARCUS BIOSCIENCES INC (RCUS:NYSE) News Sources
New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan
01-07-2026
yahoo.com
Bristol-Myers Squibb (BMY) Joins Arcus Biosciences to Test a New Two-Drug Kidney Cancer Combination
01-07-2026
yahoo.com
An Arcus Insider Sold 68,569 Shares but Kept 1.2 Million After a 200% Run
13-07-2026
fool.com
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
21-07-2026
yahoo.com
Arcus Biosciences and Summit Therapeutics Enter into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
22-07-2026
yahoo.com
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
22-07-2026
yahoo.com
SMMT Shares Updated Ivonescimab Survival Data From NSCLC Study
23-07-2026
yahoo.com
Summit Therapeutics Inc (SMMT) Q2 2026 Earnings Call Highlights: Strong Cash Position and ...
24-07-2026
yahoo.com
SMMT's Q2 Loss Wider Than Expected, Ivonescimab Development in Focus
24-07-2026
yahoo.com
Arcus Biosciences Announces New Employment Inducement Grants
27-07-2026
yahoo.com
What is the current price of ARCUS BIOSCIENCES INC (RCUS:NYSE)?
The current price of ARCUS BIOSCIENCES INC (RCUS:NYSE) is $27.84.
ARCUS BIOSCIENCES INC (RCUS:NYSE) absolute price change since previous trading day?
The absolute price change of ARCUS BIOSCIENCES INC (RCUS:NYSE) since the previous trading day is $-0.58.
ARCUS BIOSCIENCES INC (RCUS:NYSE) percentage price change since previous trading day?
The percentage price change of ARCUS BIOSCIENCES INC (RCUS:NYSE) since the previous trading day is -2.0408%.
What is the most recent average sentiment score for ARCUS BIOSCIENCES INC (RCUS:NYSE)?
The most recent average sentiment score for ARCUS BIOSCIENCES INC (RCUS:NYSE) is 75 out of 100.
What is the most recent average sentiment for ARCUS BIOSCIENCES INC (RCUS:NYSE)?
The most recent sentiment for ARCUS BIOSCIENCES INC (RCUS:NYSE) is .
SEC-8K** Filing Available For ARCUS BIOSCIENCES INC (RCUS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.